Login / Signup

Vismodegib resistant mutations are not selected in multifocal relapses of locally advanced basal cell carcinoma after vismodegib discontinuation.

M IghilahrizM BenfoddaH SharpeN SoufirS MourahN DumazM BattistellaA SavinaF BouquetS NikolaevNicole Basset-Seguin
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2019)
Keyphrases
  • basal cell carcinoma
  • locally advanced
  • rectal cancer
  • neoadjuvant chemotherapy
  • squamous cell carcinoma
  • radiation therapy
  • phase ii study
  • open label
  • double blind